台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    117.0
  • 漲跌
    ▼0.5
  • 漲幅
    -0.43%
  • 成交量
    55
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-元大-豐原站前 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-豐原站前 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/240118.0000.00118.0001150.01%
2024/04/2300.002117.00117.50-2115-1.74%
2024/04/150117.5000.00117.0001070.01%
2024/04/120118.0000.00118.0001040.01%
2024/04/110119.5000.00119.5001010.01%
2024/04/100126.500126.50127.00095-0.03%
2024/04/090124.0000.00124.000770.00%
2024/03/2800.002122.25122.50-267-2.98%
2024/03/260123.5000.00123.000630.02%
2024/03/222123.2600.00122.502603.38%
2024/03/130116.5000.00116.500390.02%
2024/01/300111.5000.00110.000310.07%
2024/01/190.3111.5000.00112.000.3291.02%
2024/01/120.4112.0000.00112.000.4291.37%
2024/01/102111.0000.00111.002286.93%
2024/01/020115.501115.00115.50-125-3.97%
2023/12/292115.0000.00115.002248.02%
2023/12/110.2114.0000.00113.500.2210.68%
2023/08/3100.001111.50111.50-130-3.33%
2023/08/281110.5000.00110.501303.29%
2023/08/141112.0000.00111.501303.32%
2023/07/101108.5000.00108.501392.51%
2023/04/1300.001118.00119.50-147-2.09%
2023/04/101121.0000.00120.501392.56%
2023/04/0600.001118.50120.00-137-2.69%
2023/03/021109.5000.00110.001362.77%
2023/01/131105.5000.00105.501382.57%
2023/01/120107.0000.00106.000380.01%
2023/01/111106.0000.00106.001392.55%
2022/12/261105.5000.00107.001402.50%
2022/08/1500.001113.50113.50-122-4.41%
2022/07/2100.001113.00112.00-144-2.26%
2022/07/1900.001107.00109.50-143-2.30%
2022/07/1800.000.1106.00107.00-0.142-0.26%
2022/06/240.198.2000.0098.400.1460.11%
2022/06/220.199.0300.0098.000.1460.17%
2022/06/020101.0000.0099.600440.08%
2022/05/16199.6000.0098.701412.42%
2022/05/121109.0000.00109.001332.98%
2022/03/3100.001135.50135.00-121-4.75%
2022/03/2200.002131.25131.00-219-10.32%
2022/03/1800.000.5127.00128.00-0.518-2.70%
2022/03/1700.002126.25126.50-218-10.95%
2022/03/1500.002.1125.50125.00-2.121-9.64%
2022/01/130.1126.0000.00126.000.1230.34%
2021/11/121126.5000.00127.001293.36%
2021/11/100125.0000.00124.000300.03%
2021/11/091124.5000.00124.501293.36%
2021/11/081126.0000.00126.001293.44%
2021/08/100150.0000.00152.500350.01%
2021/07/270151.5000.00151.000340.01%
2021/06/0900.000.4147.00147.00-0.444-0.89%
2021/06/0800.001147.00147.00-144-2.23%
2021/06/0700.002146.25146.50-245-4.40%
2021/06/0400.002146.00146.00-245-4.42%
2021/05/2700.004147.75147.00-447-8.44%
2021/05/2500.002147.00147.50-246-4.27%
2021/05/2400.001146.00146.00-147-2.13%
2021/05/171140.0000.00140.001472.12%
2021/04/282146.0000.00146.502375.27%
2021/04/1200.001147.00150.50-136-2.77%
2021/04/092148.5000.00145.502355.67%
2021/04/012139.750.2140.50139.501.8305.84%
2021/03/3100.002143.75143.00-229-6.80%
2021/03/2600.000.1139.50141.00-0.127-0.36%
2021/03/221138.5000.00140.501253.87%
2021/03/052130.2500.00131.002277.33%
2021/02/013121.5000.00121.503358.41%
2020/12/141123.5000.00123.501342.90%
2020/12/0700.001127.50127.50-132-3.08%
2020/12/031126.5000.00127.001323.09%
2020/11/0900.000.1114.50113.50-0.129-0.34%
2020/10/151113.0000.00113.001342.90%
2020/10/130.1113.5000.00113.000.1350.28%
2020/10/1200.000.1116.00113.50-0.135-0.14%
2020/09/150.1111.5000.00111.500.1480.10%
2020/07/0300.001108.00107.50-162-1.60%
2020/07/0200.001107.50107.50-162-1.61%
2020/06/3000.004107.50107.50-462-6.45%
2020/06/2400.007115.29116.00-759-11.68%
2020/06/1900.001114.50114.50-155-1.80%
2020/06/1800.001115.00115.00-154-1.84%
2020/06/1100.003114.50112.00-353-5.59%
2020/06/0500.002113.75113.00-255-3.57%
2020/05/212109.0000.00110.002523.79%
2020/05/191107.5000.00107.001511.95%
2020/05/1800.001107.00108.00-151-1.96%
2020/05/1300.001108.50108.50-148-2.08%
2020/05/1200.001107.00108.00-147-2.11%
2020/05/111106.0000.00106.001442.24%
2020/03/18190.7000.0090.501362.78%
2020/03/10299.9000.00100.002287.08%
2020/03/0900.001100.00100.00-127-3.63%
2020/03/021100.0000.00100.501263.73%
2020/02/2600.001101.00101.00-126-3.83%
2020/02/071101.0000.00101.001273.67%
2020/01/312100.5000.00100.502257.72%
2020/01/301100.502100.50101.50-125-3.90%
2020/01/2000.0010102.50102.00-1023-42.71%
2020/01/0600.0010102.50101.50-1023-43.20%
2020/01/0300.001102.00102.00-122-4.51%
2020/01/0200.006102.58102.50-621-28.24%
2019/12/3100.005102.00102.00-520-24.06%
2019/12/172102.0000.00102.0021910.33%
2019/11/1500.001102.00102.00-121-4.66%
2019/11/0500.003101.67102.00-321-13.91%
2019/11/041102.5000.00102.501214.59%
2019/10/163102.0000.00102.0032412.20%
2019/10/152101.5000.00101.502257.83%
2019/09/1800.002102.00102.00-237-5.37%
2019/07/1700.003103.00103.00-344-6.73%
2019/07/0200.007111.50111.50-743-16.21%
2019/07/012111.001111.00111.001412.40%
2019/06/2400.001110.00110.00-141-2.40%
2019/06/061109.5000.00109.501422.33%
2019/05/3100.001110.00110.00-141-2.38%
2019/05/081108.5000.00109.501412.43%
2019/04/261108.5000.00109.001392.52%
2019/04/241109.0000.00109.501392.53%
2019/04/191108.5000.00107.501382.57%
2019/04/031107.5000.00107.501342.87%
2019/03/1400.003110.00110.00-325-11.77%
2019/03/1100.001109.00108.50-125-3.92%
2019/02/2500.002109.25110.00-223-8.35%
2019/02/2200.001108.50108.50-123-4.28%
2019/01/251105.5000.00105.501224.42%
2019/01/1500.001107.50106.50-125-3.97%
2018/12/031105.5000.00106.001273.59%
2018/11/301105.0000.00105.001273.58%
2018/11/291106.0000.00104.501283.55%
2018/11/2800.001104.00105.00-128-3.53%
2018/11/1300.000103.50103.00029-0.15%
2018/11/0500.001106.00106.00-130-3.30%
2018/10/31199.3000.0099.301293.43%
2018/07/3000.001111.00110.50-181-1.22%
2018/07/120124.5000.00124.000820.05%
2018/06/0500.002126.00126.00-2121-1.64%
2018/05/242125.5000.00125.0021261.59%
2018/05/162124.5000.00125.0021281.56%
2018/05/1500.001127.00126.00-1128-0.78%
2018/05/141124.5000.00126.0011310.76%
2018/05/093128.6700.00129.0031272.36%
2018/05/0400.002128.50128.50-2117-1.70%
2018/04/272120.5000.00124.0021171.70%
2018/04/032127.2500.00127.5021631.23%
2018/03/1900.0010129.00127.50-10176-5.66%
2018/01/261123.0000.00122.5011610.62%
2018/01/2500.001125.00123.50-1161-0.62%
2018/01/1800.001121.50121.50-1134-0.74%
2018/01/101111.5000.00112.0011020.98%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音